» » »

Multiple Myeloma Genome Omaha NE

The sequencing of the first three multiple myeloma whole genomes has been completed by U.S. scientists, who said this success will lead to a better understanding of this form of blood cancer and advance efforts to develop new therapies.

Kenneth Harvey Cowan, MD
(402) 559-4238
Eppley Inst Rm 2016 986805 Nebraska Medical Ctr,
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Case Western Reserve Univ Sch Of Med, Cleveland Oh 44106
Graduation Year: 1975

Data Provided by:
Andrew O Wahl
(402) 559-9800
988095 Nebraska Medical Ctr
Omaha, NE
Specialty
Radiation Oncology

Data Provided by:
Jean L Grem, MD
(402) 559-6210
987680 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Saaib Al Shehadat, MD, MRCP
(402) 559-5163
987680 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Weining Zhen, MD
(402) 552-3844
987521 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Okayama Univ, Fac Of Med, Okayama, Japan
Graduation Year: 1986

Data Provided by:
Bruce G Gordon, MD
(402) 559-7257
982168 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1983

Data Provided by:
James Lloyd Harper, MD
(402) 559-7257
982168 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ne Coll Of Med, Omaha Ne 68198
Graduation Year: 1985

Data Provided by:
James Olen Armitage, MD
(402) 559-7290
987680 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Ne Coll Of Med, Omaha Ne 68198
Graduation Year: 1973
Hospital
Hospital: N H S Univ Nebraska Med Ctr, Omaha, Ne
Group Practice: University Medical Associates Univ Of Nebraska Medical Ctr

Data Provided by:
Lori Jo Maness, MD
(402) 559-3742
987680 Nebraska Medical Ctr
Omaha, NE
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Suny-Hlth Sci Ctr At Syracuse, Coll Of Med, Syracuse Ny 13210
Graduation Year: 1997

Data Provided by:
Natarajan V Raman
(402) 559-9800
988095 Nebraska Medical Ctr
Omaha, NE
Specialty
Radiation Oncology

Data Provided by:
Data Provided by:

Multiple Myeloma Genome

Provided By:

WEDNESDAY, July 29 (HealthDay News) -- The sequencing of the first three multiple myeloma whole genomes has been completed by U.S. scientists, who said this success will lead to a better understanding of this form of blood cancer and advance efforts to develop new therapies.

The analysis of DNA from more than 50 patient samples was conducted as part of the Multiple Myeloma Genomics Initiative. Overall, more than 250 patient samples have been collected and additional multiple myeloma genomes are being sequenced, according to a news release from The Broad Institute.

The first three complete genomes should be available online to researchers within the next several months, the news release stated.

The data from this research "will play an important role in developing better treatment options for individuals who derive little benefit from existing therapies and may ultimately help provide multiple myeloma patients with the most appropriate treatment for his or her disease. Furthermore, knowledge from this effort could also benefit patients with other types of cancer," Louise Perkins, chief scientific officer of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC), said in a news release from the Broad Institute.

This research initiative "has created an unprecedented opportunity to examine an extraordinary breadth of genomic information to pinpoint the most important genes and cellular processes driving the disease," added Jeffrey Trent, co-principal investigator on the Multiple Myeloma Genomics Initiative. "Such a remarkable dataset exists for very few other cancers; it will no doubt pave the way toward personalized medicine for multiple myeloma patients."

More information

The American Cancer Society has more about multiple myeloma.

SOURCE: The Broad Institute, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com